Watanabe T, Nakasaki H, Mitomi T
Department of Surgery, School of Medicine, Tokai University, Kanagawa, Japan.
Tokai J Exp Clin Med. 1990 Jul;15(4):327-34.
An inhibition enzyme-linked immunosorbent assay (Inhibition ELISA) system for adriamycin has been established. In this assay system, polyclonal anti-adriamycin antiserum produced in rabbits was used. The assay system showed sensitivity for adriamycin in the range of 0.1-2.5 micrograms/ml (0.53-4.23 nmoles per ml). This assay system was applied to analyze the cross-reactive properties of substances with chemical structures similar to that of adriamycin. The cross-reactive properties of six kinds of adriamycin derivatives (Epirubicin, Daunorubicin, Pirarubicin, Aclarubicin, SM-5887 and MX-2) against anti-adriamycin antiserum were measured. The cross-reactive properties of each derivative against the antiserum differed in accordance with the differences in the position of their functional groups attached to the anthracyclic ring. The antiserum recognized the -epi type of -OH group at the -4' position on sugar chains as well as number of sugar chains attached to the anthracyclic ring, and it also recognized the glycoloyl or acetyl and/or ethyl group at position 9 on the anthracyclic ring. With this assay system, the antigenic determinant sites of the anticancer drugs were inferred.
已建立一种用于阿霉素的抑制酶联免疫吸附测定(Inhibition ELISA)系统。在该测定系统中,使用了兔产生的多克隆抗阿霉素抗血清。该测定系统对阿霉素的灵敏度范围为0.1 - 2.5微克/毫升(每毫升0.53 - 4.23纳摩尔)。此测定系统用于分析与阿霉素化学结构相似的物质的交叉反应特性。测定了六种阿霉素衍生物(表柔比星、柔红霉素、吡柔比星、阿克拉霉素、SM - 5887和MX - 2)对抗阿霉素抗血清的交叉反应特性。每种衍生物对抗血清的交叉反应特性因连接在蒽环上的官能团位置不同而有所差异。该抗血清识别糖链上4'位的 - 表型 - OH基团以及连接在蒽环上的糖链数量,还识别蒽环9位的羟乙酰基或乙酰基和/或乙基。利用该测定系统,推断了抗癌药物的抗原决定簇位点。